Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Capital Expenditures (2016 - 2026)

Myriad Genetics has reported Capital Expenditures over the past 17 years, most recently at $4.7 million for Q4 2025.

  • Quarterly Capital Expenditures rose 30.56% to $4.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.6 million through Dec 2025, down 17.89% year-over-year, with the annual reading at $15.6 million for FY2025, 17.89% down from the prior year.
  • Capital Expenditures was $4.7 million for Q4 2025 at Myriad Genetics, up from $2.8 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $23.5 million in Q1 2023 and troughed at -$14.6 million in Q4 2021.
  • The 5-year median for Capital Expenditures is $5.8 million (2022), against an average of $7.2 million.
  • Year-over-year, Capital Expenditures tumbled 284.81% in 2021 and then surged 490.0% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at -$14.6 million in 2021, then skyrocketed by 200.0% to $14.6 million in 2022, then plummeted by 31.51% to $10.0 million in 2023, then tumbled by 64.0% to $3.6 million in 2024, then soared by 30.56% to $4.7 million in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Capital Expenditures are $4.7 million (Q4 2025), $2.8 million (Q3 2025), and $2.8 million (Q2 2025).